Developing 1,2,3,4-tetrahydro-5H-aryl[1,4]diazepin-5-ones and Related Scaffolds as Poly-(ADP-ribosyl) Polymerase (PARP) Inhibitors and Exploring Their Targeted Polypharmacology with Kinases
TR Number
Date
2017-06-08
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Virginia Tech
Abstract
Description
Keywords
Poly-(ADP-Ribosyl) Polymerase (PARP), cyclin-dependent kinase 1 (CDK1), triple negative breast cancer (TNBC), benzodiazepines, isoform specific inhibitors